General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

yellow-cardJanuary 26 2015

The medicines regulator has issued guidance on the Yellow Card Scheme for health professionals to report adverse incidents with medicines and medical devices.

As part of the ‘Protecting patients from avoidable harm’ programme, the MHRA has summarised:

•    the product types which can be included in the reports
•    the sorts of information to report
•    specific areas of interest for adverse drug reactions reporting
•    the Black Triangle Scheme
•    how to deal with a medical device suspected of causing an adverse effect.

In addition, the webpage lists resources on guidance and online learning, including training modules available for pharmacists and nurses.

It reminds health professionals to report all serious suspected ADRs for established medicines and vaccines, even if the effect is well recognised. In addition, it says it is particularly interested in receiving Yellow Card reports of suspected ADRs:

•    in children
•    in patients that are over 65
•    to biological medicines and vaccines
•    associated with delayed drug effects and interactions
•    to complimentary remedies such as homeopathic and herbal products.

For adverse events involving a medical device, the device should be quarantined. It should not be thrown away, repaired or returned to the supplier until the MHRA has carried out its own investigation. Devices should only be sent to the MHRA for investigation at its request.

Link:

MHRA announcement

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...